«Oncogene Fusion

Below is an extended Oncogene Fusion patents listing. Click here to return to the Oncogene Fusion main in depth entry.

Patents :
US Patent No.	Title
7255862	ALVAC/FIV constructs
6380171	Pro-protein converting enzyme
6329179	Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
6281329	Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
6224882	Insect cells or fractions as adjuvant for antigens
6183752	Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
6156567	Truncated transcriptionally active cytomegalovirus promoters
6156316	Oncogene fusion protein peptide vaccines
6130066	Vectors having enhanced expression and methods of making and uses thereof
6090393	Recombinant canine adenoviruses, method for making and uses thereof
6034212	SH3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof
6004777	Vectors having enhanced expression, and methods of making and uses thereof
5990091	Vectors having enhanced expression, and methods of making and uses thereof
5965714	Method for the covalent attachment of polysaccharides to protein molecules
5955089	Strain selection of pneumococcal surface proteins
6451769	Compositions and methods for administering Borrelia DNA
6485729	Neuraminidase-supplemented compositions
7195876	Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
7189404	Strain selection of pneumococcal surface proteins
7163789	Cancer diagnosis method
6951649	Methods of making neuraminidase-supplemented compositions
6939671	Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
6916634	Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
6914047	Secreted protein HEMAE80
6861234	Method of epitope discovery
6759217	Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
6699692	Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
6638516	Strain selection of pneumococcal surface proteins
6525174	Precerebellin-like protein
6509452	Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
6500613	Pneumococcal surface proteins and uses thereof
4837237	Therapy using glucosidase processing inhibitors

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.